Analysis of signal transduction of inflammatory cytokines in bone destruction

骨破坏中炎症细胞因子的信号转导分析

• 批准号: 12470393
• 负责人: TAKAHASHI Naoyuki
• 金额: $ 10.56万
• 依托单位: MATSUMOTO DENTAL UNIVERSITY (2001)Showa University (2000)
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (B)
• 财政年份: 2000
• 资助国家: 日本
• 起止时间: 2000 至 2001
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-12470393/
• 关键词: Osteoclasts; Macrophage; Osteoblast; Inflammatory cytokine; p38 MAP kinase; Lipopolysaccharide; ERK; RANKL

The mechanism of osteoclastogenesis induced by lipopolysaccharide (LPS) was studied in cocultures of mouse osteoblasts and bone marrow cells. LPS stimulated osteoclastogenesis and prostaglandin E_2 (PGE_2) production in the cocultures, both of which were inhibited by NS398, a cyclooxygenase-2 inhibitor. LPS stimulated receptor activator of NF-κB ligand (RANKL) mRNA expression, and inhibited osteoprotegerin (OPG) mRNA expression in osteoblasts. NS398 inhibited only LPS-induced down-regulation of OPG mRNA expression, suggesting that LPS-stimulated PGE_2 production is important for the down-regulation of OPG. Indeed, NS398 failed to inhibit LPS-induced osteoclastogenesis in cocultures containing OPG knockout mouse-derived osteoblasts. Calcium/protein kinase C (PKC) inhibitors and PD98059 [mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor] suppressed RANKL mRNA expression in osteoblasts, and inhibited osteoclastogenesis in the cocultures treated with LPS. LPS induced phosphorylation of MEK and ERK in osteoblasts, and this induction was inhibited by calcium/PKC inhibitors. In addition, PD98059 and NS398 inhibited interleukin 1 (IL-1)-induced osteoclastogenesis in the cocultures, but only PD98059 suppressed RANKL mRNA expression induced by IL-1 in osteoblasts. These results suggest that LPS and IL-1 similarly promote osteoclastogenesis through two parallel events : enhancement of RANKL expression through calcium/PKC signals followed by MEK/ERK signals, and suppression of OPG production mediated by PGE_2.

在小鼠成骨细胞与骨髓细胞共培养的基础上，研究了脂多糖（LPS）诱导破骨细胞生成的机制。LPS刺激破骨细胞生成和前列腺素E_2（PGE_2）的产生，这两种作用均被环氧合酶-2抑制剂NS 398抑制。LPS刺激成骨细胞核因子κB配体受体激活因子（RANKL）mRNA表达，抑制成骨细胞骨保护素（OPG）mRNA表达。NS 398仅抑制LPS诱导的OPG mRNA表达下调，提示LPS刺激的PGE_2产生在OPG表达下调中起重要作用。事实上，在含有OPG敲除小鼠来源的成骨细胞的共培养物中，NS 398未能抑制LPS诱导的破骨细胞生成。钙/蛋白激酶C（PKC）抑制剂和PD 98059 [丝裂原活化蛋白激酶（MAPK）/细胞外信号调节激酶（ERK）激酶（MEK）抑制剂]抑制成骨细胞中RANKL mRNA的表达，并抑制LPS处理的共培养物中的破骨细胞生成。LPS诱导成骨细胞MEK和ERK磷酸化，这种诱导作用可被钙/PKC抑制剂抑制。此外，PD 98059和NS 398抑制共培养物中白细胞介素1（IL-1）诱导的破骨细胞生成，但只有PD 98059抑制IL-1诱导的成骨细胞RANKL mRNA表达。这些结果表明，LPS和IL-1通过两个平行事件促进破骨细胞生成：通过钙/PKC信号随后MEK/ERK信号增强RANKL表达，以及通过PGE_2介导抑制OPG产生。

项目成果

Takahashi, N. et al.: "Cells of bone : osteoclast generation."Principles of Bone Biology, Second Edition, Volume 1, eds. Billezikian, J.P., Raisz, LG., Rodan. G. A. Academic press. 109-126 (2002)

Takahashi, N. 等人：“骨细胞：破骨细胞生成。”《骨生物学原理》，第二版，第 1 卷，编辑。

Takahashi, N. et al.: "Generation of murine osteoclasts from bone marrow."Bone Res. Protocols. (in press). (2002)

Takahashi, N. 等人：“从骨髓中产生小鼠破骨细胞。”Bone Res。

Itoh, K. et al.: "Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-κB ligand."Endocrinology. 142. 3656-3662 (2001)

Itoh, K. 等人：“骨形态发生蛋白 2 通过核因子-κB 配体的受体激活剂刺激破骨细胞分化和存活。内分泌学”142. 3656-3662 (2001)。

Yanai T, Katagiri T, Akiyama S, Imada M, Yamashita T, Chiba H, Takahashi N. Suda T: "Expression of mouse osteocalcin transcripts, OG1 and OG2, is differently regulated in bone tissues and osteoblast cultures"J. Bone Mineral Metab.. 19. 345-351 (2001)

Yanai T、Katagiri T、Akiyama S、Imada M、Yamashita T、Chiba H、Takahashi N. Suda T：“小鼠骨钙素转录物 OG1 和 OG2 的表达在骨组织和成骨细胞培养物中受到不同的调节”J。

Takahashi N, Udagawa N, Suda T: "Principles of Bone Biology, ed by Raisz LG, Rodan GA, Bilezikian JP [Cells of bone : Osteoclast generation]"Academic Press. 1695(109-126) (2002)

Takahashi N、Udakawa N、Suda T：“骨生物学原理，Raisz LG、Rodan GA、Bilezikian JP 编辑[骨细胞：破骨细胞生成]”学术出版社。